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Abstract
Cerebral venous sinus thrombosis (CVST) usually is
taken care of by medical management or neuro-interventional
vascular techniques. Some cases of CVST may take a malignant
course if the intracranial pressure increases excessively. This
increase in pressure is because of oedema in brain tissue due to
impediment in venous return and/or intracerebral haemorrhage.
Neurosurgical experience has shown remarkable recovery in
these moribund patients if appropriate surgical intervention is
done within reasonable time. Emergent decompressive cran-
iotomy or other neurosurgical interventions are the only appro-
priate treatment in these malignant forms of CVST to prevent
mortality and severe morbidity.  
Introduction
With a worldwide availability of non-invasive imag-
ing studies such as Computerized Tomography (CT) and
Magnetic Resonance Imaging (MRI) scans, cerebral venous
sinus thrombosis (CVST) has been diagnosed more fre-
quently since the last decade. In the pre-CT era angiography
with a venogram was the diagnostic test.  This test is still the
gold standard but due to convenience and excellent reliabil-
ity magnetic resonance venogram is now the diagnostic test
of choice. CT scan may be negative in a fraction of proven
CVST cases and the classical "delta sign" may be seen in
only a few.  Depending upon the extension of the thrombo-
sis, CT scan and MRI may also show global or focal cere-
bral oedema, haemorrhagic conversion of infarction, intrac-
erebral haematoma, and signs of herniation. Antithrombotic
treatments which include intravenous heparin, endovascular
thrombolysis and oral anticoagulants are now well accepted
treatments of CVST.  In majority of the cases the medical
treatment is sufficient but in a few cases the surgical treat-
ment becomes essential to save life and prevent severe neu-
rologic impairment.  
Some cases of cvst may take a malignant
course
For understanding the role of surgery in CVST, the
concept of malignant CVST is being introduced. 
The clinical presentation of CVST can be highly var-
ied1. The presentation may be insidious with headache as
the most prominent symptom. Focal neurological deficits
and/or seizures is the presenting symptom in about three
quarter of CVST cases. An uncommon presentation is a rap-
idly progressive malignant form where patient quickly dete-
riorates neurologically ending up in coma.  Patients may
present with this severe form of CVST to medical attention
or alternatively a mild case of CVST may develop into a
malignant form several days later regardless of appropriate
medical treatment.2 According to a multinational, multi-
center study, ISCVT (international Study on Cerebral Vein
and Dural Sinus Thrombosis), which prospectively fol-
lowed 624 patients, 13.9% presented with a Glasgow Coma
Score (GCS) between 9-13 and 5.2% were comatose, i.e.,
had a GCS less than 9 on presentation.3 Close to 9% of
patients in that cohort ended up severely impaired or dead
(2.2% severely impaired with a modified Rankin Scale 4 or
5 and 6.6% dead due to CVST).  It is these malignant cases
of CVST that can benefit most from surgical intervention.  
Mortality in cvst is usually due to increased
intracranial pressure
While most of the CVST cases resolve over time
even if they have focal areas of haemorrhages, a transient
increase in intracranial pressure (ICP) can put some on a
malignant course.  The pathogenesis of high ICP in these
cases is a combination of oedema due to impaired venous
drainage along with mass effect of intracerebral haemor-
rhage (ICH) that occurs due to venous infarcts and may take
form of large clots.  A massive swelling ensues throughout
the brain which in turn leads to trans-tentorial herniation of
the medial temporal lobe with compression of the midbrain
or central coning.  These events are clinically characterized
by deep coma with or without pupillary dilatation. In a post-
mortem study on 35 patients who died of CSVT, 32 showed
signs of raised ICP such as cerebral swelling, trans-tentori-
al temporal lobe herniation, and brain stem and occipital
lobe haemorrhages.4
Coma and intracerebral haemorrhage are
poor prognostic factors in cvst
The prognosis of CVST has improved over time.3,5
This probably is a reflection of the ease in diagnosis of
benign forms of the disease by CT and MRI as well as a
wider acceptance of appropriate therapeutic interventions.
A significant number of patients, however, still end up with
severe morbidity or mortality. Poor prognostic factors iden-
tified by the ISCVT study were coma on presentation and
haemorrhage on CT scan.  Death toll due to CVST in the
ISCVT study was 4.3% in the acute phase and another 2.3%
during the follow up.  An earlier prospective study of 59
patients and a retrospective study of 62 patients with CVST
had also suggested coma and intracerebral haemorrhage as
predictors of poor outcome.6,7 Other factors that were asso-
ciated with poor outcome were papillodema, age older than
33 years, and involvement of straight sinus.  
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Surgical intervention may be the only appro-
priate treatment in cases of malignant cvst
CVST is primarily treated by medical intervention
and by interventional radiology if needed.  Most of the neu-
rologists and internists are not very clear about the role of
neurosurgery in CVST.  The matter of fact is that neuro-
surgery plays a significant role in the treatment of CVST.
There are several neurosurgical procedures that need to be
considered in the context of CVST.
Decompressive craniotomy
Decompressive craniotomy is a procedure done in
cases of cranial trauma, massive cerebral infarcts, and post-
neurosurgical cerebral oedema when increased intracranial
pressure (ICP) is a serious problem.  This procedure can
make a remarkable difference in a malignant case of CVST.  
For CVST decompressive craniectomy was
described in the 1980's.4,8 In one of the largest documented
accounts of decompressive craniotomy for CVST, dating
back to pre-CT/MRI era, 32 out of 70 CVST patients under-
went this procedure.4 In this group of patients who had sur-
gery survival was 54% and of those who survived neurolog-
ic improvement was observed in 89%.  Since the neurolog-
ical status prior to surgery was not described the value of
decompressive craniotomy cannot be judged very well from
that study.   But in a recent study which is a series of 3 cases
that underwent emergent surgery after developing bilateral-
ly dilated and fixed pupil from CVST related cerebral
swelling, decompressive craniectomy made a remarkable
difference.9 Two of these patients returned to their normal
daily life, and the third one, in which there was a delay of
several hours between pupillary dilatation and surgery, was
left with severe impairments but regained consciousness
and some ability to communicate. The outcome of the first
two cases was phenomenal.  In another series of 4 cases in
which patients were taken to operating room because of pro-
gressive neurological deterioration and CT signs of immi-
nent herniation, the outcome of was very good also.10 Prior
to surgery the GCS of these patients ranged from 6-13 and
two of them had deteriorated despite adequate medical man-
agement. These patients underwent single or multiple pro-
cedures with or without resection of infracted tissue and
evacuation of blood clot. Due to decompressive craniotomy
they were not only salvaged, they eventually recovered with
no residual deficits or only mild expressive dysphasia.  
Since a large cohort can not be established for a valid
randomized controlled trial on the role of surgery in CVST,
we need to learn lessons from other examples.  In posttrau-
matic cerebral hypertension benefit of decompressive
bifrontal craniotomy has been proven statistically.11 The
benefit was greatest if the intervention was done before ICP
increased to 40 or above for a sustained period of time and
if the intervention was done within 48 hours of the injury. In
space occupying hemispheric infarction decompressive
craniotomy improved the mortality from more than 75% to
less than 35%.12 Further analysis of their data shows that if
only those patients are considered who had dilated their
pupils due to increased ICP decompressive craniotomy
actually helped reduce mortality from 110% (16/16) to 33%
(8/24). This data strongly recommends decompressive cran-
iotomy for malignant CVST.
The decompressive procedure usually consists of
removal of a large bone flap along with a dural patch either
from artificial dura or autologous tissue such as pericrani-
um, temporalis fascia, or fascia lata.  In addition to the
removal of bone flap the neurosurgeon may also consider
resecting infracted brain tissue and/or evacuation of
haematoma.13 The recommended size of dural patch is 15 to
20 cm in length and 2.5 to 3 cm in width.12 The bone flap
may be replaced after 4 to 12 weeks depending upon com-
plete resolution of swelling and medical fitness of the
patient. If thrombosis is in the cerebellar veins with conse-
quent oedematous cerebellar infarcts, suboccipital cranioto-
my is the appropriate procedure. 
Open surgical thrombectomy
Open surgical thrombectomy consists of craniotomy
over the thrombosed sinus to remove the blood clot and then
repair the sinus with or without a patch.  Alternatively it
may consist of a small keyhole opening over the sinus to
pass a catheter to pull out the clot. Technically this proce-
dure may work well for superior sagittal sinus or transverse
sinus CVST.  Few published reports have documented suc-
cessful use of this technique.14-16 Open thrombectomy with
local infusion of thrombolytic agents was attempted only
when these patients had deteriorated neurologically on sys-
temic anticoagulation. With the current use of endovascular
approaches by interventional neuro-radiologists, the advan-
tage of open surgical thrombectomy is very limited.
CSF shunt
In the ISCVT study of 624 patients shunts were per-
formed in 1.6%.3 A need for a ventriculoperitoneal shunt
usually arises when venous thrombosis in the posterior fossa
causes cerebellar swelling and subsequent fourth ventricle
obliteration.  The hydrocephalus that ensues may be fatal and
needs to be addressed emergently. A temporizing procedure,
extra-ventricular drainage of cerebrospinal fluid (CSF) by an
external ventriculostomy, may be considered if spontaneous
resolution of the blockage in CSF flow is expected once the
cerebellar swelling subsides. If hydrocephalus is severe to
begin with or recurs upon closing the external ventricular
drain, a ventriculoperitoneal shunt or other variations of CSF
shunts may have to be inserted.  Some patients with CVST
develop persistent symptoms of benign intracranial hyper-
tension even after the acute phase of the CVST is over and
may need a ventriculoperitoneal or a lumboperitoneal shunt
eventually.17
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Venous bypass
The idea of a microvascular anastomosis of a venous
channel bypassing the thrombosed sinus is interesting but
very challenging. Microsurgical revascularization with a
bypass graft between right transverse sinus and superficial
jugular vein for a case of bilateral thrombosis of transverse
sinuses and internal jugular veins has been described.18
This resulted in significant improvement. This kind of
microvascular feat is hard to accomplish unless the CVST
is localized to the transverse and sigmoid sinus.  With recent
advances in neuro-radiological interventional techniques,
the value of complex procedures like microvascular bypass
is probably only historical.
Surgical intervention for CVST sequelae
CVST can lead to few other problems that demand a
neurosurgeon's attention.  Several cases of subdural
haematoma secondary to CVST have been reported that
required evacuation by burr holes or by craniotomy.19-21
Dural arteriovenous fistula that may need surgery has also
been documented as a rare long-term complication of later-
al sinus thrombosis.5
Surgical conditions that may lead to CVST
While malignant form of CVST may need surgical
intervention, certain surgical conditions themselves may
predispose to CVST. This includes vascular malformation,
particularly dural fistula.  In the international study ISCVT
of 624 cases, arteriovenous malformation and venous
anomaly was found in one case each and dural fistula was
found in 11 cases (1.6%) as the risk factors for CVST.3 In
the same study, cranial trauma was identified as a risk fac-
tor for CVST in 1.1%, surgical procedure as a risk factor in
2.7%, and neurosurgical procedures as a risk factor 0.6% of
cases. In another study that focused on posterior fossa sur-
gery (suboccipital craniotomy or translabyrinthine craniec-
tomy) 5 out of 117 (4.6%) cases developed subsequent
symptomatic transverse sinus thrombosis on the operated
side.17
Medical management after surgical interven-
tion in CVST:
Anticoagulation therapy may be resumed shortly
after surgical decompression, albeit at a lower level.  Keller
et al11 in their series of 4 cases that underwent emergent
decompressive craniotomy for malignant CVST describe
resumption of anticoagulation at half dosage 12 hours post-
operatively and then at full dosage after 24 hours.  They did
not see any unwanted effect of early anticoagulation such as
post-operative bleeding or enlargement of intracerebral
haematoma. Their medical management included observa-
tion in the intensive care unit with continuous ICP monitor-
ing and if needed repeat craniotomy to extend decompres-
sion or institution of barbiturate coma and hypothermia
along with appropriate use of hyperventilation and osmotic
therapy.
Conclusion
Current evidence, although all class III, suggests that
in malignant CVST even if the patients are in their worst
neurological state, neurosurgical intervention should be
aggressive. One has to remember however that while surgi-
cal intervention will improve survival, some may end up
severely handicapped and this should be discussed with the
family.
In ISCVT, the largest study so far on CVST (624
patients), decompressive craniotomy was performed on
1.4%.3 In that study 5% presented with coma (GCS < 9),
4.3% expired during the hospitalization and another 2.3%
died due to CVST during a median follow-up of 16 months.
From the study it appears that the number of CVST patients
who had a malignant course was 3-6 times those who had
neurosurgical intervention.  The ratio should have been
opposite.  Surgical attempts to prevent mortality should be
more than the number of deaths.  
With the advancement in medical management the
benefits of surgical intervention has been ignored.
Emphasis on the medical management and endovascular
treatment for CVST should not overlook the value of surgi-
cal intervention. Decompressive craniotomy may produce
remarkable recovery in patients with malignant CVST.
Some of the factors that impose a poor prognosis to the
CVST should be the indications for neurosurgical interven-
tion. These include coma, anisocoria, CT / MRI showing
intracerebral haemorrhage, signs of imminent herniation
and severe cerebral oedema. When patients develop signs of
herniation, emergent decompressive craniotomy may be the
only appropriate treatment.  The case series of Stefini et al9
and Keller et al11 clearly show that if decompressive cran-
iotomy is done in a timely fashion, those patients who are at
the brink of death may have excellent recovery and may
return to their normal life.  
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